Cognetivity Neurosciences
West Point
About Cognetivity Neurosciences
Cognetivity Neurosciences is a medical technology company developing an AI platform for early detection of cognitive impairment, dementia and Alzheimer's disease.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $5.2M
- Funding stage: IPO
- Last round: Post-IPO Equity (Oct 2022)
- Ticker: cnsx:CGN
- Website: cognetivity.com
- Phone: +44 020 3002 3628
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Health Care, Health Diagnostics, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/cognetivity-neurosciences-191953 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.